Both in Pharmaceuticals
Bolt Biotherapeutics vs Kyntra Bio
Over the past year BOLT returned +12.6% and KYNB returned −58.3%; their daily moves had a correlation of -0.03.
BOLT +12.6% KYNB −58.3%Growth of $1, one year, split-adjusted
| Metric | BOLT | KYNB |
|---|---|---|
| Price | $6.54 | $3.96 |
| Market cap | $15.4M | $16.0M |
| Today | −0.46% | −8.12% |
| 1 month | +86.3% | −33.6% |
| 6 months | +42.5% | −44.4% |
| Year to date | +19.6% | — |
| 1 year | +17.2% | — |
| Revenue growth (YoY) | −99.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −154400.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | — |
| Net cash | $17.6M | $91.3M |
| Dividend yield | — | — |
| Volatility (60d) | 112.3% | 57.0% |
| Short % of float | 1.1% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).